SHA 067. Bioabsorbable-polymer-DES Saudi registry, with 3year followup
نویسندگان
چکیده
منابع مشابه
067 Rosas.pmd
The giant otter, Pteronura brasiliensis, is one of the largest carnivores of South America (Duplaix, 1980). Its historical distribution extended from the northern part of the South American continent to the north-central portion of Argentina (Carter and Rosas, 1997). Because of the destruction of its habitat and intense hunting pressure due to the demand of the international “haute couture” for...
متن کاملBioabsorbable polymer optical waveguides for deep-tissue photomedicine.
Advances in photonics have stimulated significant progress in medicine, with many techniques now in routine clinical use. However, the finite depth of light penetration in tissue is a serious constraint to clinical utility. Here we show implantable light-delivery devices made of bio-derived or biocompatible, and biodegradable polymers. In contrast to conventional optical fibres, which must be r...
متن کاملeqr 067 Competing Risks
Consider a unit which can experience any one of k competing failure types, and suppose that for each unit we observe the time to failure, T , and the type of failure, C ∈ {1, 2, . . . , k}. The case of observing the pair (T, C) is termed “competing risks” in the statistical literature. After considering some examples we review basic notation and theory of competing risks. In particular we consi...
متن کامل059-067 Gram
Introduction Listeriosis is a food-borne disease which primarily affects people in particular risk-groups (immuno-suppressed, elderly, neonates) in which lethality is as high as 25%. The disease does occur in out-breaks but most cases appear as sporadic cases. The disease is primarily associated with ready-to-eat (RTE) food products with extended (refrigerated) shelf life. Outbreaks have mostly...
متن کاملSix- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
BACKGROUND Everolimus, an active immunosuppressive and antiproliferative agent of the same family as sirolimus (rapamycin), has demonstrated significant reduction of neointimal proliferation in animal studies. The First Use To Underscore restenosis Reduction with Everolimus (FUTURE) I trial was the first in-human experience to evaluate the safety and efficacy of everolimus-eluting stents (EES),...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Saudi Heart Association
سال: 2011
ISSN: 1016-7315
DOI: 10.1016/j.jsha.2011.02.068